The Role of DACT Family Members in Tumorigenesis and Tumor Progression.

Szczegóły
Abstrakt

Tytuł:: The Role of DACT Family Members in Tumorigenesis and Tumor Progression.
Autorzy:: Zeng Y; Department of Neurosurgery, Guizhou Provincial People's Hospital, Guiyang, China.
Zhang J; Department of Anesthesiology, Guizhou Provincial People's Hospital, Guiyang, China.
Yue J; Department of Neurosurgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Han G; Department of Neurosurgery, Guizhou Provincial People's Hospital, Guiyang, China.
Liu W; Department of Respiratory and Critical Care Medicine, Guizhou Provincial People's Hospital, Guiyang, China.
Liu L; Department of Respiratory and Critical Care Medicine, Guizhou Provincial People's Hospital, Guiyang, China.
Lin X; Department of Nephrology, Guizhou Provincial People's Hospital, Guiyang, China.
Zha Y; Department of Nephrology, Guizhou Provincial People's Hospital, Guiyang, China.
Liu J; Department of Neurosurgery, Guizhou Provincial People's Hospital, Guiyang, China.
Tan Y; Department of Neurosurgery, Guizhou Provincial People's Hospital, Guiyang, China.
Źródło:: International journal of biological sciences [Int J Biol Sci] 2022 Jul 11; Vol. 18 (11), pp. 4532-4544. Date of Electronic Publication: 2022 Jul 11 (Print Publication: 2022).
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
Język:: English
Imprint Name(s):: Original Publication: Lake Haven, N.S.W., Australia : Ivyspring International, c2004-
MeSH Terms:: Biomarkers, Tumor*
Carcinogenesis*/genetics
Cell Differentiation ; Cell Proliferation/genetics ; Humans
References:: Front Cell Dev Biol. 2021 Jul 28;9:660159. (PMID: 34395416)
Dev Dyn. 2006 Sep;235(9):2620-30. (PMID: 16881060)
Nat Rev Cancer. 2021 Sep;21(9):592-604. (PMID: 34239104)
Mol Ther Nucleic Acids. 2021 Feb 26;24:610-621. (PMID: 33898109)
Mol Cell Biochem. 2018 Dec;449(1-2):305-314. (PMID: 29786763)
J Cell Physiol. 2017 Aug;232(8):2104-2111. (PMID: 27714812)
Tumour Biol. 2017 Oct;39(10):1010428317711089. (PMID: 29037126)
Cancer Prev Res (Phila). 2013 Aug;6(8):791-800. (PMID: 23803417)
Oncogene. 2016 Dec 15;35(50):6359-6365. (PMID: 27212036)
Oncotarget. 2017 Aug 7;8(39):65687-65698. (PMID: 29029464)
J Histochem Cytochem. 2011 Jul;59(7):711-8. (PMID: 21525190)
Cell Death Discov. 2021 May 20;7(1):119. (PMID: 34016964)
J Biol Chem. 2013 May 24;288(21):15006-14. (PMID: 23580654)
J Pathol. 2013 Jun;230(2):194-204. (PMID: 22806826)
Onco Targets Ther. 2018 May 15;11:2815-2830. (PMID: 29844680)
Cancer Cell Int. 2020 Jul 31;20:358. (PMID: 32760225)
Pharmacol Res. 2018 Mar;129:318-328. (PMID: 29199082)
Science. 2004 Oct 1;306(5693):114-7. (PMID: 15459392)
PLoS One. 2013;8(1):e54868. (PMID: 23349981)
Nat Cell Biol. 2021 Mar;23(3):257-267. (PMID: 33723425)
Cell. 2011 Mar 4;144(5):646-74. (PMID: 21376230)
Exp Ther Med. 2018 Dec;16(6):4909-4917. (PMID: 30542447)
Cell Res. 2004 Oct;14(5):439-40. (PMID: 15538976)
J BUON. 2018 Mar-Apr;23(2):361-365. (PMID: 29745077)
Mol Cancer. 2018 Jun 21;17(1):96. (PMID: 29929545)
Oncogene. 2005 Feb 24;24(9):1607-14. (PMID: 15580286)
Oncotarget. 2016 Oct 25;7(43):70924-70935. (PMID: 27708215)
J Biol Chem. 2015 May 8;290(19):12346-54. (PMID: 25825496)
Anal Cell Pathol (Amst). 2021 Jul 24;2021:5555452. (PMID: 34350095)
Sci Rep. 2017 Aug 24;7(1):9285. (PMID: 28839145)
Immunol Rev. 2019 Mar;288(1):97-111. (PMID: 30874343)
Nat Rev Drug Discov. 2017 Mar;16(3):203-222. (PMID: 28209991)
Acta Pharm Sin B. 2021 Jun;11(6):1400-1411. (PMID: 34221859)
Nature. 1986 May 15-21;321(6067):209-13. (PMID: 2423876)
Epigenetics. 2013 Apr;8(4):373-82. (PMID: 23449122)
Gene Expr Patterns. 2014 Nov;16(2):122-9. (PMID: 25266145)
J Cell Physiol. 2019 Apr;234(4):4375-4384. (PMID: 30191992)
J Biomed Res. 2012 Sep;26(5):319-24. (PMID: 23554767)
Biochem Pharmacol. 2020 Feb;172:113772. (PMID: 31866302)
Oncogene. 2015 May 14;34(20):2575-85. (PMID: 25023701)
Biol Res. 2019 Jun 10;52(1):31. (PMID: 31182157)
Cell Res. 2014 Aug;24(8):912-24. (PMID: 24980960)
Trends Cancer. 2017 Feb;3(2):113-125. (PMID: 28718442)
Mol Biol Res Commun. 2019 Jun;8(2):53-58. (PMID: 31531376)
Am J Physiol Renal Physiol. 2010 Oct;299(4):F740-51. (PMID: 20685821)
Cancer Lett. 2017 Apr 1;390:126-136. (PMID: 28108314)
BMC Biochem. 2011 Jun 30;12:33. (PMID: 21718540)
Nucleic Acids Res. 2019 Jan 25;47(2):533-545. (PMID: 30535081)
Mol Carcinog. 2010 May;49(5):508-19. (PMID: 20232357)
Int J Clin Exp Med. 2015 Jan 15;8(1):714-21. (PMID: 25785048)
Gene Expr Patterns. 2010 Feb-Mar;10(2-3):140-3. (PMID: 20170752)
PLoS One. 2014 Nov 06;9(11):e112336. (PMID: 25375359)
Cell Death Dis. 2017 Aug 10;8(8):e2981. (PMID: 28796248)
Braz J Cardiovasc Surg. 2020 Jan 01;34(6):711-722. (PMID: 31545578)
Nature. 2009 Nov 19;462(7271):315-22. (PMID: 19829295)
Front Mol Biosci. 2021 Jul 22;8:633299. (PMID: 34368222)
Biotechnol Adv. 2019 May - Jun;37(3):459-475. (PMID: 30797096)
Semin Cell Dev Biol. 2018 Sep;81:78-87. (PMID: 29107170)
J Cancer. 2019 Apr 20;10(7):1755-1763. (PMID: 31205531)
Dev Cell. 2005 May;8(5):703-15. (PMID: 15866161)
Nat Rev Mol Cell Biol. 2019 Jan;20(1):21-37. (PMID: 30108335)
Am J Cancer Res. 2014 Sep 06;4(5):518-27. (PMID: 25232493)
Cancer Lett. 2021 Jul 28;511:15-25. (PMID: 33945837)
Clin Chim Acta. 2013 Sep 23;424:53-65. (PMID: 23669186)
Breast Cancer Res. 2013 Mar 12;15(2):R23. (PMID: 23497530)
Oncotarget. 2016 Dec 6;7(49):81423-81434. (PMID: 27833078)
Nat Cell Biol. 2002 May;4(5):351-7. (PMID: 11941372)
Dev Cell. 2002 Apr;2(4):449-61. (PMID: 11970895)
J Biol Chem. 2008 Dec 19;283(51):35679-88. (PMID: 18936100)
J Biomed Sci. 2017 Jan 11;24(1):6. (PMID: 28077137)
Free Radic Biol Med. 2012 Jan 1;52(1):7-18. (PMID: 22019631)
Int J Oncol. 2003 Apr;22(4):907-13. (PMID: 12632086)
World J Surg Oncol. 2013 Mar 07;11:57. (PMID: 23496880)
Cancer Cell. 2008 Jun;13(6):529-41. (PMID: 18538736)
Oncol Lett. 2018 Mar;15(3):3287-3294. (PMID: 29435071)
Development. 2004 Dec;131(23):5909-21. (PMID: 15539487)
Nat Rev Mol Cell Biol. 2021 Jun;22(6):425-438. (PMID: 33772227)
PLoS One. 2012;7(3):e34004. (PMID: 22470507)
Cancer Biomark. 2015;15(1):11-7. (PMID: 25524937)
Cell Res. 2005 Apr;15(4):237-46. (PMID: 15857578)
Clin Epigenetics. 2018 Feb 27;10(1):26. (PMID: 30359298)
Dev Cell. 2016 May 23;37(4):311-325. (PMID: 27184734)
Nat Rev Cancer. 2018 May;18(5):296-312. (PMID: 29546880)
Nat Rev Drug Discov. 2017 Apr;16(4):241-263. (PMID: 28280262)
Nucleic Acids Res. 2011 Dec;39(22):9508-20. (PMID: 21880597)
Nat Rev Cancer. 2015 Jun;15(6):321-33. (PMID: 25998712)
Am J Cancer Res. 2014 Nov 19;4(6):710-24. (PMID: 25520862)
Development. 2004 Oct;131(19):4725-34. (PMID: 15329348)
Dev Dyn. 2014 Mar;243(3):428-39. (PMID: 23417991)
PLoS One. 2010 Oct 29;5(10):e13764. (PMID: 21048943)
Int J Clin Exp Pathol. 2017 Dec 01;10(12):11580-11587. (PMID: 31966514)
J Exp Clin Cancer Res. 2018 Dec 14;37(1):317. (PMID: 30547803)
Cell. 2004 Jan 23;116(2):235-46. (PMID: 14744434)
Clin Epigenetics. 2018 Aug 3;10(1):103. (PMID: 30075814)
Sci Rep. 2017 Jun 12;7(1):3325. (PMID: 28607412)
Cancer Res. 2021 Sep 15;81(18):4652-4667. (PMID: 34183354)
Nutrients. 2019 Oct 08;11(10):. (PMID: 31597327)
Mol Cancer. 2020 Apr 27;19(1):79. (PMID: 32340605)
Oncotarget. 2016 Apr 5;7(14):17957-69. (PMID: 26919254)
Mol Med. 2012 Dec 20;18:1402-11. (PMID: 23073659)
J Pers Med. 2020 Nov 12;10(4):. (PMID: 33198090)
Pharmacol Ther. 2018 Aug;188:45-79. (PMID: 29454856)
Nat Rev Genet. 2015 Jul;16(7):421-33. (PMID: 26077373)
Int J Mol Med. 2005 Jun;15(6):1045-9. (PMID: 15870912)
Contributed Indexing:: Keywords: Apoptosis; Cancer; DACT family members; Invasion; Prognosis; Proliferation
Substance Nomenclature:: 0 (Biomarkers, Tumor)
Entry Date(s):: Date Created: 20220722 Date Completed: 20220725 Latest Revision: 20220812
Update Code:: 20240105
PubMed Central ID:: PMC9295065
DOI:: 10.7150/ijbs.70784
PMID:: 35864965
: Czasopismo naukowe

Full Text Finder

Disheveled-associated antagonist of β-catenin (DACT), which ubiquitously expressed in human tissue, is critical for regulating cell proliferation and several developmental processes in different cellular contexts. In addition, DACT is essential for some other cellular processes, such as cell apoptosis, migration and differentiation. Given the importance of DACT in these cellular processes, many scientists are gradually interested in studying the role of DACT in tumorigenesis and cancer progression. This review article focuses on the latest research regarding the essential functions and potential DACT mechanisms in the occurrence and progression of tumors. Our study indicates that DACT may act as a tumor biomarker for cancer diagnosis and prognosis, as well as a promising therapeutic target in cancers.
Competing Interests: Competing Interests: The authors have declared that no competing interest exists.
(© The author(s).)

Informacja